• Arizona’s bioscience industry gains momentum in education, funding • State still faces uncertainty in federal funding and sustained state funding • Leaders identify key policy changes as crucial for future industry success
More than two decades after Arizona leaders charted a course for the state’s budding bioscience industry, growth has come by way of four more medical schools, increased funding for research and entrepreneurship, job growth, the creation of an industry association and nationwide momentum.
The rearview mirror shines, but in paving a way forward with the launch of the 2025-2030 Arizona Bioscience Roadmap, commissioned by the Flinn Foundation, dips in federal funding and policy hurdles create new uncertainty for the industry.
But with goals outlined at the outset —